S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CRISPR TherapeuticsQIAGENBio-TechneNeurocrine BiosciencesRepligen
SymbolNASDAQ:CRSPNYSE:QGENNASDAQ:TECHNASDAQ:NBIXNASDAQ:RGEN
Price Information
Current Price$125.69$50.00$361.69$109.51$212.39
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.51.71.82.11.5
Analysis Score3.33.31.33.31.5
Community Score2.72.32.33.62.6
Dividend Score0.00.01.70.00.0
Ownership Score1.70.81.71.71.7
Earnings & Valuation Score0.01.91.91.91.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$147.67$56.37$352.30$129.22$204.75
% Upside from Price Target17.48% upside12.74% upside-2.60% downside18.00% upside-3.60% downside
Trade Information
Market Cap$9.48 billion$11.39 billion$14.03 billion$10.29 billion$11.18 billion
Beta2.370.411.131.010.94
Average Volume2,488,645972,289194,645910,338380,833
Sales & Book Value
Annual Revenue$289.59 million$1.53 billion$738.69 million$788.10 million$270.24 million
Price / Sales32.747.4619.0013.0541.35
Cashflow$0.82 per share$2.49 per share$6.73 per share$0.69 per share$1.44 per share
Price / Cash154.1120.0753.77158.60147.51
Book Value$17.02 per share$11.14 per share$36.13 per share$6.92 per share$20.36 per share
Price / Book7.384.4910.0115.8310.43
Profitability
Net Income$66.86 million$-41,460,000.00$229.30 million$37.01 million$21.41 million
EPS$1.17$1.43$3.86$0.39$1.07
Trailing P/E RatioN/A61.7357.87117.75259.01
Forward P/E RatioN/A20.4161.8330.25127.95
P/E GrowthN/A1.297.23N/A4.18
Net Margins-273.10%11.18%32.69%8.96%13.40%
Return on Equity (ROE)-20.72%17.51%12.20%18.18%6.58%
Return on Assets (ROA)-18.35%8.44%8.09%9.50%5.00%
Dividend
Annual PayoutN/AN/A$1.28N/AN/A
Dividend YieldN/AN/A0.35%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A33.16%N/AN/A
Years of Consecutive Dividend GrowthN/AN/A1 YearsN/AN/A
Debt
Debt-to-Equity RatioN/A0.52%0.22%N/A0.21%
Current Ratio16.53%1.46%5.14%1.89%13.67%
Quick Ratio16.53%1.22%4.13%1.86%12.13%
Ownership Information
Institutional Ownership Percentage66.43%43.64%93.75%95.25%84.33%
Insider Ownership Percentage17.10%9.00%3.80%4.30%1.70%
Miscellaneous
Employees3045,3002,300845761
Shares Outstanding75.43 million227.75 million38.80 million93.94 million52.62 million
Next Earnings Date4/27/2021 (Estimated)5/5/2021 (Estimated)4/29/2021 (Estimated)5/5/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.